When to start antiretroviral therapy: the need for an evidence base during early HIV infection

BACKGROUND: Strategies for use of antiretroviral therapy (ART) have traditionally focused on providing treatment to persons who stand to benefit immediately from initiating the therapy. There is global consensus that any HIV+ person with CD4 counts less than 350 cells/μl should initiate ART. However...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Lundgren, Jens D, Babiker, Abdel G, Gordin, Fred M, Borges, Álvaro H, Neaton, James D
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2013
Konular:
Debate
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3682886/
https://ncbi.nlm.nih.gov/pubmed/23767777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1741-7015-11-148
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller